Administering amifostine prior to and during cisplatin infusions can significantly reduce the risk of severe ototoxicity

Author:  

Publisher: Adis International

ISSN: 0114-9954

Source: Reactions Weekly, Vol.1, Iss.1218, 2008-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract